Stocks

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks Market Movers TipRanks 50 Index AI Stocks Largest Companies by Market Cap

Top ETFs by Upside Top ETFs by Smart Score Top Gainers/ Losers/ Active ETFs

Unusual Options Activity

Research Tools

Trending Stocks Compare Stocks Compare ETFs Trump Dashboard

Daily Feeds

Daily Analyst Ratings Daily Insider Trading Tracker

Calendars

Earnings Calendar Dividend Calendar Economic Calendar IPO Calendar Stock Splits Stock Buybacks FDA Calendar Market Holidays

Calculators

Dividend Calculator Dividend Yield Calculator Options Profit Calculator

Economic Indicators

Inflation Rate Unemployment Rate

Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Private Companies

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Rapha Capital PE Life Sciences Fund VI Investment Portfolio

Companies Invested In

Company Name

Sector

Investment Round Value

Funding Round

Announcement Date

PC:FIZEM

Healthcare, Biotechnology & Medical Devices

$30.00M

Series A

Jan 14, 2025

TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.

Find Us on

Newsletter SubscriptionEnter your email to receive our newsletter

Terms of Use Privacy Policy FAQ

EducationHow To Use TipRanks TipRanks Labs Glossary FAQs

About usAbout TipRanks Contact Us Reviews

Working With TipRanksEnterprise Solutions Top Online Brokers Become an Affiliate TipRanks News Wire

PlansPlans & Pricing API for Institutions

CalendarsEarnings Calendar Dividend Calendar Economic Calendar Stock Split Calendar

CalculatorsDividend Calculator Dividend Yield Calculator Options Profit Calculator

ScreenersStock Screener ETF Screener Screener Technical Analysis Screener

CalendarsEarnings Calendar Dividend Calendar Economic Calendar Stock Split Calendar

CalculatorsDividend Calculator Dividend Yield Calculator Options Profit Calculator

ScreenersStock Screener ETF Screener Screener Technical Analysis Screener

Find Us on

Terms of Use Privacy Policy FAQ

Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.